Global Intraocular Lenses Market - Segmented by Product, End-Use and Geography - Growth, Trends, and Forecast (2022 - 2030)

The global intraocular Lenses (IOLs) market is expected to register a growth rate of nearly 5% during the forecast period, 2018 to 2023. Intraocular lenses (IOLs) are implantable medical devices used for vision correction. Rising diabetic cases and associated cataract and diabetic retinopathy complications are expected to boost the global market.

Rising Ophthalmic Issues to Boost Market Growth

Rise in ocular conditions such as cataract, and diabetic retinopathy across the world is a major aspect assisting market growth. According to national eye institute, the United States recoded 7.7 million diabetic retinopathy cases, and 24 million cataract cases and expected to reach 11.3 million and 38 million respectively by 2030. In addition, the American Association of Ophthalmology states the major cause of visual impairment around the world is reported to be cataract, and geriatric ocular issues are emerging as prime factors in the developing countries. Hence, such a rise in the ophthalmic conditions across the globe is expected to drive the growth of the IOL market over the forecast period.

High Cost of Treatment to Hinder Market Growth

Higher costs associated with ophthalmic surgeries, such as cataract surgery, and other retinal correction surgeries are expected to drive the market growth over the forecast period. The cost of the IOL plays a vital role in the process of their adoption for vision correction or impairment surgeries. The approximate cost of an IOL implant surgery is USD 1,400 to USD 3,500 per eye.
In addition, the reimbursement is provided for IOL implants only in conditions where it is a necessity, and not in case of vision correction lenses, thereby increasing the financial burden on the patients. The cataract surgery in the United States costs around USD 3600 to USD 6600 without the insurance coverage. Thus, the increasing costs of IOLs and the poor reimbursement coverage are expected to hamper the market growth over the forecast period.

Asia-Pacific to Witness the Lucrative Growth

Rising incidences of cataract, diabetic retinopathy, and macular degeneration in the United States can be attributed to the dominance of the North America region IOL market in 2016. Moreover, presence of reimbursement policies for essential ophthalmic surgeries and a definite regulatory framework are enhancing growth in the market.
On the other hand, Asia-Pacific is expected to emerge as the fastest growing segment over the forecast period owing to government initiatives to include eye care in social security systems, rise in geriatric population, increasing cataract cases, and projected rise in diabetic population.
Diabetic patients are susceptible to macular degeneration, diabetic retinopathy, and cataract. Hence the increase in the diabetic population results in the rising need for IOLs. India accounted for a diabetic population of 50.8 million whereas the Eastern and Western Pacific regions accounted for 59 million and 77 million diabetic patients respectively according to the International Diabetes Federation.
The developing countries such as China, India, Malaysia, and Singapore are experiencing growth in the IOL market, owing to the growth in medical tourism industry and massive patient pool. In addition, the increasing initiatives of government and non-government organizations to provide affordable eye care in the Asia-Pacific region are expected to boost the market growth.

Key Developments in the Market

• October, 2017 - Alcon declared the introduction of its new intraocular lens (IOL) Clareon, at European Society for Cataract.
• October, 2017 - Alcon announced the completion of 100 million implants of its AcrySof IOL.
• October, 2017 - Alcon received CE mark for its product AutonoMe. This is a preloaded IOL delivery system containing Clareon IOL.

Major Players - ALCON INC., BAUSCH & LOMB INCORPORATED, CARL ZEISS MEDITEC AG, EYEKON MEDICAL INC., HOYA CORPORATION, HUMANOPTICS AG, JOHNSON AND JOHNSON VISION CARE INC., LENSTEC, INC. AND STAAR SURGICAL COMPANY, amongst others.

Reasons to Purchase this Report

• The current and future outlook of the intraocular lenses (IOLs) market in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• Information regarding the segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in excel)

Customization of the Report

• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports